This is the second of a two-part series on the evolution of angel investing. To read part one, click here. As groups of high-net-worth individuals continue to band together in the form of angel investment networks and funds, they’re creating new opportunities for funding for mid-stage startups. But to some entrepreneurs, they’re also starting to […]
The number of angel investors in the U.S. has jumped 60 percent since 2002, and the number of dollars they’ve invested in companies has gone up even faster. Not to mention that a few new angel groups have sprouted just within the last year to invest especially in life science companies. Given all of […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A Cleveland company developing catheter infection prevention technology has reached a big milestone in the commercialization process — but to do so, it’s had to make a big shift in strategy. Great Lakes Pharmaceuticals has just begun the first clinical study of safety and efficacy of its antimicrobial solution to prevent infections associated with indwelling catheters […]
Northeast Ohio's largest angel investor group, North Coast Angel Fund, is nearing an $8 million close on its second fund.
Early stage investment group North Coast Angel Fund is raising money for a second fund, having pulled in commitments for $800,000. In all likelihood, North Coast Angels are looking to raise $8 million for the group's second fund.
TheraVasc Inc., which is reformulating a drug to treat vascular diseases, has raised a $1.8 million Series A1 round of investment capital. But the company isn't stopping there -- it's looking to add about $450,000 to the round.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Early stage venture group Ohio TechAngel Funds has raised $2.5 million for its third investment fund. Like the group's previous funds, Ohio TechAngel Fund III will invest in Ohio-based technology companies in the life and physical sciences, and information technology industries.
Neuros Medical Inc., a start-up company that is developing a neurostimulation device to block chronic pain, has landed $1.8 million from several investors during its first round of venture financing. Neuros Medical will use the money to begin product development, hire a chief technology officer and complete clinical studies on its device that stimulates nerves to alleviate pain.
The company is developing a disposable device that measures the length of a woman's cervix to help predict risks of preterm birth. It is potentially easier, less costly and just as accurate as the transvaginal ultrasound device used in only high-risk pregnancies. It could be in the market by 2010.